BBB Foods Inc. Class A Common Shares (TBBB)

This concept has exploded with 2,772 locations across North America. And it's just getting started.

BBB Foods operates about 2,800 Tiendas 3B stores and clocked $2.83 billion in sales last year.

It may be riskier now than ever. Here's an alternative.

The market has dropped quite a bit, and many experts see things getting worse.

The company recently announced the closing of a successful public offering for 21 million of its class A common shares at a price of $28.25 per share.

Whether you want higher risk and higher reward, stability with a high yield, or international opportunity, we have a great stock idea for you.

These two stocks have tons of potential.

Want to outperform the market next year? These two stocks could help you do it.

A big new winner and a discounted giant.

We think these two stocks can deliver massive returns for long-term investors.

TBBB stock results show that BBB Foods beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Strong earnings and revenue guidance from Nvidia sparked a tech stock surge, with Nasdaq 100 and S&P 500 hitting record highs.

Wall Street experienced a muted session on Wednesday morning as traders adopted a cautious stance ahead of the Federal Reserve meeting minutes release at 2 p.m. EDT and Nvidia Corp.

As of March 25, 2024, five stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Market for IPOs expected to rebound in 2024 after inflation & interest rate rise hit new listings in 2022-23. 2023 saw 50% decrease in IPOs globally.

Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a drug developer this year.